nodes	percent_of_prediction	percent_of_DWPC	metapath
Benazepril—MTHFR—liver cancer	0.914	1	CbGaD
Benazepril—Proteinuria—Sorafenib—liver cancer	0.00207	0.024	CcSEcCtD
Benazepril—Protein urine present—Sorafenib—liver cancer	0.00204	0.0237	CcSEcCtD
Benazepril—Hyponatraemia—Sorafenib—liver cancer	0.00133	0.0154	CcSEcCtD
Benazepril—Gastritis—Sorafenib—liver cancer	0.00117	0.0136	CcSEcCtD
Benazepril—Pancreatitis—Sorafenib—liver cancer	0.00112	0.013	CcSEcCtD
Benazepril—Serum creatinine increased—Epirubicin—liver cancer	0.00109	0.0127	CcSEcCtD
Benazepril—Neutropenia—Sorafenib—liver cancer	0.00107	0.0124	CcSEcCtD
Benazepril—Erectile dysfunction—Sorafenib—liver cancer	0.00105	0.0122	CcSEcCtD
Benazepril—Serum creatinine increased—Doxorubicin—liver cancer	0.00101	0.0117	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00101	0.0117	CcSEcCtD
Benazepril—Acute coronary syndrome—Sorafenib—liver cancer	0.001	0.0116	CcSEcCtD
Benazepril—Myocardial infarction—Sorafenib—liver cancer	0.000997	0.0116	CcSEcCtD
Benazepril—Erythema multiforme—Sorafenib—liver cancer	0.000864	0.01	CcSEcCtD
Benazepril—Tinnitus—Sorafenib—liver cancer	0.000852	0.00989	CcSEcCtD
Benazepril—Flushing—Sorafenib—liver cancer	0.000848	0.00985	CcSEcCtD
Benazepril—Arrhythmia—Sorafenib—liver cancer	0.000816	0.00948	CcSEcCtD
Benazepril—Alopecia—Sorafenib—liver cancer	0.000807	0.00937	CcSEcCtD
Benazepril—Jaundice cholestatic—Epirubicin—liver cancer	0.000765	0.00889	CcSEcCtD
Benazepril—Cough increased—Epirubicin—liver cancer	0.000734	0.00853	CcSEcCtD
Benazepril—Angioedema—Sorafenib—liver cancer	0.000726	0.00844	CcSEcCtD
Benazepril—Syncope—Sorafenib—liver cancer	0.000713	0.00828	CcSEcCtD
Benazepril—Leukopenia—Sorafenib—liver cancer	0.000712	0.00827	CcSEcCtD
Benazepril—Jaundice cholestatic—Doxorubicin—liver cancer	0.000708	0.00822	CcSEcCtD
Benazepril—Loss of consciousness—Sorafenib—liver cancer	0.000699	0.00812	CcSEcCtD
Benazepril—Cough—Sorafenib—liver cancer	0.000694	0.00806	CcSEcCtD
Benazepril—Coordination abnormal—Epirubicin—liver cancer	0.000684	0.00795	CcSEcCtD
Benazepril—Musculoskeletal pain—Epirubicin—liver cancer	0.00068	0.0079	CcSEcCtD
Benazepril—Cough increased—Doxorubicin—liver cancer	0.000679	0.00789	CcSEcCtD
Benazepril—Arthralgia—Sorafenib—liver cancer	0.000677	0.00786	CcSEcCtD
Benazepril—Myalgia—Sorafenib—liver cancer	0.000677	0.00786	CcSEcCtD
Benazepril—Hyperkalaemia—Epirubicin—liver cancer	0.00066	0.00767	CcSEcCtD
Benazepril—Melaena—Epirubicin—liver cancer	0.000657	0.00763	CcSEcCtD
Benazepril—Anaphylactic shock—Sorafenib—liver cancer	0.000649	0.00754	CcSEcCtD
Benazepril—Infection—Sorafenib—liver cancer	0.000645	0.00749	CcSEcCtD
Benazepril—Shock—Sorafenib—liver cancer	0.000638	0.00742	CcSEcCtD
Benazepril—Thrombocytopenia—Sorafenib—liver cancer	0.000635	0.00738	CcSEcCtD
Benazepril—Blood urea increased—Epirubicin—liver cancer	0.000635	0.00737	CcSEcCtD
Benazepril—Coordination abnormal—Doxorubicin—liver cancer	0.000633	0.00736	CcSEcCtD
Benazepril—Musculoskeletal pain—Doxorubicin—liver cancer	0.000629	0.00731	CcSEcCtD
Benazepril—Hyperkalaemia—Doxorubicin—liver cancer	0.000611	0.0071	CcSEcCtD
Benazepril—Melaena—Doxorubicin—liver cancer	0.000607	0.00706	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000591	0.00687	CcSEcCtD
Benazepril—Hypertonia—Epirubicin—liver cancer	0.000589	0.00684	CcSEcCtD
Benazepril—Blood urea increased—Doxorubicin—liver cancer	0.000587	0.00682	CcSEcCtD
Benazepril—Dyspnoea—Sorafenib—liver cancer	0.000578	0.00672	CcSEcCtD
Benazepril—Dyspepsia—Sorafenib—liver cancer	0.000571	0.00663	CcSEcCtD
Benazepril—Fatigue—Sorafenib—liver cancer	0.000559	0.0065	CcSEcCtD
Benazepril—Photosensitivity—Epirubicin—liver cancer	0.000556	0.00645	CcSEcCtD
Benazepril—Constipation—Sorafenib—liver cancer	0.000555	0.00645	CcSEcCtD
Benazepril—Hypertonia—Doxorubicin—liver cancer	0.000545	0.00633	CcSEcCtD
Benazepril—Gastrointestinal pain—Sorafenib—liver cancer	0.000531	0.00616	CcSEcCtD
Benazepril—Photosensitivity—Doxorubicin—liver cancer	0.000514	0.00597	CcSEcCtD
Benazepril—Abdominal pain—Sorafenib—liver cancer	0.000513	0.00596	CcSEcCtD
Benazepril—Anaphylactoid reaction—Epirubicin—liver cancer	0.000504	0.00586	CcSEcCtD
Benazepril—Cerebrovascular accident—Epirubicin—liver cancer	0.000498	0.00578	CcSEcCtD
Benazepril—Hyponatraemia—Epirubicin—liver cancer	0.00049	0.00569	CcSEcCtD
Benazepril—Hypersensitivity—Sorafenib—liver cancer	0.000478	0.00555	CcSEcCtD
Benazepril—Face oedema—Epirubicin—liver cancer	0.000471	0.00547	CcSEcCtD
Benazepril—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000466	0.00542	CcSEcCtD
Benazepril—Asthenia—Sorafenib—liver cancer	0.000466	0.00541	CcSEcCtD
Benazepril—Cerebrovascular accident—Doxorubicin—liver cancer	0.000461	0.00535	CcSEcCtD
Benazepril—Pruritus—Sorafenib—liver cancer	0.000459	0.00533	CcSEcCtD
Benazepril—Blood creatinine increased—Epirubicin—liver cancer	0.000457	0.00531	CcSEcCtD
Benazepril—Hyponatraemia—Doxorubicin—liver cancer	0.000453	0.00526	CcSEcCtD
Benazepril—Orthostatic hypotension—Epirubicin—liver cancer	0.000446	0.00518	CcSEcCtD
Benazepril—Diarrhoea—Sorafenib—liver cancer	0.000444	0.00516	CcSEcCtD
Benazepril—Face oedema—Doxorubicin—liver cancer	0.000436	0.00506	CcSEcCtD
Benazepril—Gastritis—Epirubicin—liver cancer	0.000432	0.00502	CcSEcCtD
Benazepril—Dizziness—Sorafenib—liver cancer	0.000429	0.00498	CcSEcCtD
Benazepril—Blood creatinine increased—Doxorubicin—liver cancer	0.000423	0.00491	CcSEcCtD
Benazepril—Influenza—Epirubicin—liver cancer	0.000422	0.0049	CcSEcCtD
Benazepril—Asthma—Epirubicin—liver cancer	0.000422	0.0049	CcSEcCtD
Benazepril—Eosinophilia—Epirubicin—liver cancer	0.000418	0.00485	CcSEcCtD
Benazepril—Pancreatitis—Epirubicin—liver cancer	0.000413	0.0048	CcSEcCtD
Benazepril—Vomiting—Sorafenib—liver cancer	0.000413	0.00479	CcSEcCtD
Benazepril—Orthostatic hypotension—Doxorubicin—liver cancer	0.000412	0.00479	CcSEcCtD
Benazepril—Angina pectoris—Epirubicin—liver cancer	0.000411	0.00477	CcSEcCtD
Benazepril—Rash—Sorafenib—liver cancer	0.000409	0.00475	CcSEcCtD
Benazepril—Dermatitis—Sorafenib—liver cancer	0.000409	0.00475	CcSEcCtD
Benazepril—Headache—Sorafenib—liver cancer	0.000406	0.00472	CcSEcCtD
Benazepril—Bronchitis—Epirubicin—liver cancer	0.000406	0.00471	CcSEcCtD
Benazepril—Gastritis—Doxorubicin—liver cancer	0.0004	0.00464	CcSEcCtD
Benazepril—Neutropenia—Epirubicin—liver cancer	0.000394	0.00458	CcSEcCtD
Benazepril—Influenza—Doxorubicin—liver cancer	0.00039	0.00453	CcSEcCtD
Benazepril—Asthma—Doxorubicin—liver cancer	0.00039	0.00453	CcSEcCtD
Benazepril—Pollakiuria—Epirubicin—liver cancer	0.00039	0.00452	CcSEcCtD
Benazepril—Eosinophilia—Doxorubicin—liver cancer	0.000386	0.00449	CcSEcCtD
Benazepril—Nausea—Sorafenib—liver cancer	0.000385	0.00448	CcSEcCtD
Benazepril—Photosensitivity reaction—Epirubicin—liver cancer	0.000385	0.00447	CcSEcCtD
Benazepril—Pancreatitis—Doxorubicin—liver cancer	0.000383	0.00444	CcSEcCtD
Benazepril—Angina pectoris—Doxorubicin—liver cancer	0.00038	0.00441	CcSEcCtD
Benazepril—Bronchitis—Doxorubicin—liver cancer	0.000375	0.00436	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000373	0.00433	CcSEcCtD
Benazepril—Urinary tract infection—Epirubicin—liver cancer	0.000365	0.00425	CcSEcCtD
Benazepril—Neutropenia—Doxorubicin—liver cancer	0.000365	0.00424	CcSEcCtD
Benazepril—Sweating—Epirubicin—liver cancer	0.00036	0.00419	CcSEcCtD
Benazepril—Pollakiuria—Doxorubicin—liver cancer	0.00036	0.00419	CcSEcCtD
Benazepril—Photosensitivity reaction—Doxorubicin—liver cancer	0.000356	0.00414	CcSEcCtD
Benazepril—Sinusitis—Epirubicin—liver cancer	0.000353	0.0041	CcSEcCtD
Benazepril—Agranulocytosis—Epirubicin—liver cancer	0.000351	0.00408	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000345	0.00401	CcSEcCtD
Benazepril—Rhinitis—Epirubicin—liver cancer	0.000338	0.00393	CcSEcCtD
Benazepril—Urinary tract infection—Doxorubicin—liver cancer	0.000338	0.00393	CcSEcCtD
Benazepril—Hepatitis—Epirubicin—liver cancer	0.000338	0.00392	CcSEcCtD
Benazepril—Pharyngitis—Epirubicin—liver cancer	0.000335	0.00389	CcSEcCtD
Benazepril—Sweating—Doxorubicin—liver cancer	0.000334	0.00387	CcSEcCtD
Benazepril—Oedema peripheral—Epirubicin—liver cancer	0.000333	0.00386	CcSEcCtD
Benazepril—Sinusitis—Doxorubicin—liver cancer	0.000326	0.00379	CcSEcCtD
Benazepril—Agranulocytosis—Doxorubicin—liver cancer	0.000325	0.00377	CcSEcCtD
Benazepril—Erythema multiforme—Epirubicin—liver cancer	0.000319	0.00371	CcSEcCtD
Benazepril—Tinnitus—Epirubicin—liver cancer	0.000315	0.00366	CcSEcCtD
Benazepril—Flushing—Epirubicin—liver cancer	0.000313	0.00364	CcSEcCtD
Benazepril—Rhinitis—Doxorubicin—liver cancer	0.000313	0.00364	CcSEcCtD
Benazepril—Hepatitis—Doxorubicin—liver cancer	0.000312	0.00363	CcSEcCtD
Benazepril—Pharyngitis—Doxorubicin—liver cancer	0.00031	0.0036	CcSEcCtD
Benazepril—Oedema peripheral—Doxorubicin—liver cancer	0.000308	0.00357	CcSEcCtD
Benazepril—Arrhythmia—Epirubicin—liver cancer	0.000302	0.0035	CcSEcCtD
Benazepril—Alopecia—Epirubicin—liver cancer	0.000298	0.00346	CcSEcCtD
Benazepril—Erythema multiforme—Doxorubicin—liver cancer	0.000295	0.00343	CcSEcCtD
Benazepril—Tinnitus—Doxorubicin—liver cancer	0.000291	0.00338	CcSEcCtD
Benazepril—Flushing—Doxorubicin—liver cancer	0.00029	0.00337	CcSEcCtD
Benazepril—Flatulence—Epirubicin—liver cancer	0.00029	0.00336	CcSEcCtD
Benazepril—Tension—Epirubicin—liver cancer	0.000288	0.00335	CcSEcCtD
Benazepril—Nervousness—Epirubicin—liver cancer	0.000285	0.00331	CcSEcCtD
Benazepril—Back pain—Epirubicin—liver cancer	0.000284	0.0033	CcSEcCtD
Benazepril—Arrhythmia—Doxorubicin—liver cancer	0.000279	0.00324	CcSEcCtD
Benazepril—Alopecia—Doxorubicin—liver cancer	0.000276	0.00321	CcSEcCtD
Benazepril—Flatulence—Doxorubicin—liver cancer	0.000268	0.00311	CcSEcCtD
Benazepril—Tension—Doxorubicin—liver cancer	0.000267	0.0031	CcSEcCtD
Benazepril—Nervousness—Doxorubicin—liver cancer	0.000264	0.00307	CcSEcCtD
Benazepril—Vertigo—Epirubicin—liver cancer	0.000264	0.00307	CcSEcCtD
Benazepril—Syncope—Epirubicin—liver cancer	0.000263	0.00306	CcSEcCtD
Benazepril—Leukopenia—Epirubicin—liver cancer	0.000263	0.00306	CcSEcCtD
Benazepril—Back pain—Doxorubicin—liver cancer	0.000263	0.00305	CcSEcCtD
Benazepril—Palpitations—Epirubicin—liver cancer	0.00026	0.00302	CcSEcCtD
Benazepril—Loss of consciousness—Epirubicin—liver cancer	0.000258	0.003	CcSEcCtD
Benazepril—Cough—Epirubicin—liver cancer	0.000256	0.00298	CcSEcCtD
Benazepril—Myalgia—Epirubicin—liver cancer	0.00025	0.00291	CcSEcCtD
Benazepril—Arthralgia—Epirubicin—liver cancer	0.00025	0.00291	CcSEcCtD
Benazepril—Chest pain—Epirubicin—liver cancer	0.00025	0.00291	CcSEcCtD
Benazepril—Anxiety—Epirubicin—liver cancer	0.000249	0.0029	CcSEcCtD
Benazepril—Vertigo—Doxorubicin—liver cancer	0.000244	0.00284	CcSEcCtD
Benazepril—Syncope—Doxorubicin—liver cancer	0.000244	0.00283	CcSEcCtD
Benazepril—Leukopenia—Doxorubicin—liver cancer	0.000243	0.00283	CcSEcCtD
Benazepril—Palpitations—Doxorubicin—liver cancer	0.00024	0.00279	CcSEcCtD
Benazepril—Anaphylactic shock—Epirubicin—liver cancer	0.00024	0.00279	CcSEcCtD
Benazepril—Oedema—Epirubicin—liver cancer	0.00024	0.00279	CcSEcCtD
Benazepril—Loss of consciousness—Doxorubicin—liver cancer	0.000239	0.00278	CcSEcCtD
Benazepril—Infection—Epirubicin—liver cancer	0.000238	0.00277	CcSEcCtD
Benazepril—Cough—Doxorubicin—liver cancer	0.000237	0.00276	CcSEcCtD
Benazepril—Shock—Epirubicin—liver cancer	0.000236	0.00274	CcSEcCtD
Benazepril—Thrombocytopenia—Epirubicin—liver cancer	0.000235	0.00273	CcSEcCtD
Benazepril—Hyperhidrosis—Epirubicin—liver cancer	0.000232	0.00269	CcSEcCtD
Benazepril—Chest pain—Doxorubicin—liver cancer	0.000231	0.00269	CcSEcCtD
Benazepril—Myalgia—Doxorubicin—liver cancer	0.000231	0.00269	CcSEcCtD
Benazepril—Arthralgia—Doxorubicin—liver cancer	0.000231	0.00269	CcSEcCtD
Benazepril—Anxiety—Doxorubicin—liver cancer	0.000231	0.00268	CcSEcCtD
Benazepril—Hypotension—Epirubicin—liver cancer	0.000224	0.0026	CcSEcCtD
Benazepril—Oedema—Doxorubicin—liver cancer	0.000222	0.00258	CcSEcCtD
Benazepril—Anaphylactic shock—Doxorubicin—liver cancer	0.000222	0.00258	CcSEcCtD
Benazepril—Infection—Doxorubicin—liver cancer	0.00022	0.00256	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000218	0.00254	CcSEcCtD
Benazepril—Shock—Doxorubicin—liver cancer	0.000218	0.00254	CcSEcCtD
Benazepril—Thrombocytopenia—Doxorubicin—liver cancer	0.000217	0.00252	CcSEcCtD
Benazepril—Insomnia—Epirubicin—liver cancer	0.000217	0.00252	CcSEcCtD
Benazepril—Paraesthesia—Epirubicin—liver cancer	0.000215	0.0025	CcSEcCtD
Benazepril—Hyperhidrosis—Doxorubicin—liver cancer	0.000214	0.00249	CcSEcCtD
Benazepril—Dyspnoea—Epirubicin—liver cancer	0.000214	0.00248	CcSEcCtD
Benazepril—Somnolence—Epirubicin—liver cancer	0.000213	0.00248	CcSEcCtD
Benazepril—Dyspepsia—Epirubicin—liver cancer	0.000211	0.00245	CcSEcCtD
Benazepril—Hypotension—Doxorubicin—liver cancer	0.000207	0.00241	CcSEcCtD
Benazepril—Fatigue—Epirubicin—liver cancer	0.000207	0.0024	CcSEcCtD
Benazepril—Constipation—Epirubicin—liver cancer	0.000205	0.00238	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000202	0.00235	CcSEcCtD
Benazepril—Insomnia—Doxorubicin—liver cancer	0.000201	0.00233	CcSEcCtD
Benazepril—Paraesthesia—Doxorubicin—liver cancer	0.000199	0.00231	CcSEcCtD
Benazepril—Dyspnoea—Doxorubicin—liver cancer	0.000198	0.0023	CcSEcCtD
Benazepril—Somnolence—Doxorubicin—liver cancer	0.000197	0.00229	CcSEcCtD
Benazepril—Gastrointestinal pain—Epirubicin—liver cancer	0.000196	0.00228	CcSEcCtD
Benazepril—Dyspepsia—Doxorubicin—liver cancer	0.000195	0.00227	CcSEcCtD
Benazepril—Fatigue—Doxorubicin—liver cancer	0.000191	0.00222	CcSEcCtD
Benazepril—Constipation—Doxorubicin—liver cancer	0.00019	0.0022	CcSEcCtD
Benazepril—Abdominal pain—Epirubicin—liver cancer	0.00019	0.0022	CcSEcCtD
Benazepril—Gastrointestinal pain—Doxorubicin—liver cancer	0.000181	0.00211	CcSEcCtD
Benazepril—Hypersensitivity—Epirubicin—liver cancer	0.000177	0.00205	CcSEcCtD
Benazepril—Abdominal pain—Doxorubicin—liver cancer	0.000175	0.00204	CcSEcCtD
Benazepril—Asthenia—Epirubicin—liver cancer	0.000172	0.002	CcSEcCtD
Benazepril—Pruritus—Epirubicin—liver cancer	0.00017	0.00197	CcSEcCtD
Benazepril—Diarrhoea—Epirubicin—liver cancer	0.000164	0.00191	CcSEcCtD
Benazepril—Hypersensitivity—Doxorubicin—liver cancer	0.000163	0.0019	CcSEcCtD
Benazepril—Asthenia—Doxorubicin—liver cancer	0.000159	0.00185	CcSEcCtD
Benazepril—Dizziness—Epirubicin—liver cancer	0.000159	0.00184	CcSEcCtD
Benazepril—Pruritus—Doxorubicin—liver cancer	0.000157	0.00182	CcSEcCtD
Benazepril—Vomiting—Epirubicin—liver cancer	0.000152	0.00177	CcSEcCtD
Benazepril—Diarrhoea—Doxorubicin—liver cancer	0.000152	0.00176	CcSEcCtD
Benazepril—Rash—Epirubicin—liver cancer	0.000151	0.00176	CcSEcCtD
Benazepril—Dermatitis—Epirubicin—liver cancer	0.000151	0.00175	CcSEcCtD
Benazepril—Headache—Epirubicin—liver cancer	0.00015	0.00174	CcSEcCtD
Benazepril—Dizziness—Doxorubicin—liver cancer	0.000147	0.0017	CcSEcCtD
Benazepril—Nausea—Epirubicin—liver cancer	0.000142	0.00165	CcSEcCtD
Benazepril—Vomiting—Doxorubicin—liver cancer	0.000141	0.00164	CcSEcCtD
Benazepril—Rash—Doxorubicin—liver cancer	0.00014	0.00163	CcSEcCtD
Benazepril—Dermatitis—Doxorubicin—liver cancer	0.00014	0.00162	CcSEcCtD
Benazepril—Headache—Doxorubicin—liver cancer	0.000139	0.00161	CcSEcCtD
Benazepril—Nausea—Doxorubicin—liver cancer	0.000132	0.00153	CcSEcCtD
